2025-07-02 |
13D/A |
HYPD / Hyperion DeFi, Inc. |
Avenue Venture Opportunities Fund, L.P. |
435,438 |
8.53 |
0.00 |
2025-07-02 |
13D/A |
ECVT / Ecovyst Inc. |
INEOS Ltd |
0 |
0.00 |
-100.00 |
2025-07-02 |
13D/A |
SPRY / ARS Pharmaceuticals, Inc. |
Deerfield Mgmt III, L.P. |
9,724,508 |
9.90 |
-7.51 |
2025-07-01 |
13D/A |
BBIO / BridgeBio Pharma, Inc. |
Viking Global Investors Lp |
18,602,920 |
9.80 |
-15.65 |
2025-07-01 |
13D |
TCRT / Alaunos Therapeutics, Inc. |
Postma Robert W |
199,796 |
9.00 |
|
2025-07-01 |
13D/A |
RVPH / Reviva Pharmaceuticals Holdings, Inc. |
Vedanta Associates, L.P. |
6,259,806 |
8.70 |
|
2025-07-01 |
13D/A |
RVPH / Reviva Pharmaceuticals Holdings, Inc. |
Bhat Laxminarayan |
3,612,384 |
5.20 |
12.95 |
2025-06-30 |
13D/A |
BIVI / BioVie Inc. |
Acuitas Group Holdings, LLC |
3,050,394 |
15.80 |
-90.00 |
2025-06-30 |
13D/A |
KYMR / Kymera Therapeutics, Inc. |
Baker Bros. Advisors Lp |
6,666,540 |
9.50 |
11.09 |
2025-06-30 |
13D/A |
CDTX / Cidara Therapeutics, Inc. |
Ra Capital Management, L.p. |
3,365,523 |
15.80 |
207.97 |
2025-06-27 |
13D |
ZYME / Zymeworks Inc. |
EcoR1 Capital, LLC |
22,970,388 |
30.70 |
29.78 |
2025-06-27 |
13D/A |
VOR / Vor Biopharma Inc. |
Ra Capital Management, L.p. |
39,739,850 |
31.80 |
0.08 |
2025-06-27 |
13D/A |
NATR / Nature's Sunshine Products, Inc. |
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. |
64,167 |
0.35 |
-97.80 |
2025-06-26 |
13D/A |
ORGO / Organogenesis Holdings Inc. |
Ades Alan A. |
22,319,836 |
17.60 |
0.00 |
2025-06-25 |
13D/A |
SLNCF / Silence Therapeutics plc |
Griffiths Richard Ian |
34,543,302 |
24.40 |
4.95 |
2025-06-24 |
13D/A |
PCT / PureCycle Technologies, Inc. |
Sylebra Capital Llc |
34,934,774 |
19.46 |
1.81 |
2025-06-23 |
13D/A |
CMMB / Chemomab Therapeutics Ltd. - Depositary Receipt (Common Stock) |
OrbiMed Israel BioFund GP Limited Partnership |
969,807 |
4.80 |
-47.89 |
2025-06-23 |
13D/A |
STOK / Stoke Therapeutics, Inc. |
Blue Horizon Enterprise Ltd |
3,256,181 |
6.00 |
-16.64 |
2025-06-23 |
13D/A |
ADXN / Addex Therapeutics Ltd - Depositary Receipt (Common Stock) |
Dyer Timothy Mark |
18,208,437 |
12.94 |
7.98 |
2025-06-23 |
13D/A |
ENZN / Enzon Pharmaceuticals, Inc. |
Icahn Carl C |
36,056,636 |
48.60 |
0.00 |
2025-06-20 |
13D/A |
CASI / CASI Pharmaceuticals, Inc. |
He Wei-Wu |
3,735,535 |
23.80 |
14.66 |
2025-06-20 |
13D/A |
HYPD / Hyperion DeFi, Inc. |
Avenue Venture Opportunities Fund, L.P. |
435,438 |
9.99 |
0.00 |
2025-06-18 |
13D/A |
INDV / Indivior PLC |
Two Seas Capital LP |
12,072,398 |
9.70 |
1.61 |
2025-06-17 |
13D/A |
ELVN / Enliven Therapeutics, Inc. |
Orbimed Advisors Llc |
7,918,163 |
13.40 |
0.00 |
2025-06-17 |
13D/A |
BHC / Bausch Health Companies Inc. |
Paulson & Co. Inc. |
32,791,702 |
8.90 |
24.03 |
2025-06-16 |
13D |
ARVN / Arvinas, Inc. |
Logos Global Management LP |
4,800,000 |
6.40 |
|
2025-06-16 |
13D/A |
CVAC / CureVac N.V. |
dievini Hopp BioTech holding GmbH & Co KG |
82,373,544 |
36.70 |
-1.80 |
2025-06-16 |
13D/A |
MEHCQ / Chrome Holding Co. |
ABeeC 2.0, LLC |
5,722,832 |
22.00 |
1.12 |
2025-06-13 |
13D/A |
LYB / LyondellBasell Industries N.V. |
AI International Chemicals LLC |
65,285,504 |
20.30 |
0.00 |
2025-06-13 |
13D/A |
LTRN / Lantern Pharma Inc. |
BIOS Fund I, LP |
1,075,952 |
9.98 |
|
2025-06-13 |
13D/A |
PRLD / Prelude Therapeutics Incorporated |
Baker Bros. Advisors Lp |
10,269,968 |
23.50 |
0.46 |
2025-06-13 |
13D/A |
HCWB / HCW Biologics Inc. |
Wong Hing C |
501,911 |
23.38 |
-96.87 |
2025-06-13 |
13D/A |
HYPD / Hyperion DeFi, Inc. |
Avenue Venture Opportunities Fund, L.P. |
435,438 |
9.99 |
-92.72 |
2025-06-12 |
13D |
BTMD / biote Corp. |
Roystone Management Holdings LLC |
4,622,748 |
14.00 |
|
2025-06-12 |
13D/A |
SLGL / Sol-Gel Technologies Ltd. |
Arkin Moshe |
1,950,113 |
65.31 |
|
2025-06-11 |
13D/A |
LYB / LyondellBasell Industries N.V. |
AI International Chemicals LLC |
65,285,504 |
20.30 |
-0.35 |
2025-06-11 |
13D/A |
ERNA / Ernexa Therapeutics Inc. |
Cherington Charles |
41,690,775 |
37.90 |
104.04 |
2025-06-10 |
13D/A |
ENTO / Entero Therapeutics, Inc. |
Ali Arif Nasir |
230,900 |
4.90 |
-7.97 |
2025-06-10 |
13D/A |
BIOX / Bioceres Crop Solutions Corp. |
Bioceres Group PLC |
25,115,102 |
40.00 |
-9.29 |
2025-06-10 |
13D/A |
CBUS / Cibus, Inc. |
Riggs Rory B |
18,726,128 |
33.02 |
364.95 |
2025-06-09 |
13D |
ENTO / Entero Therapeutics, Inc. |
Ali Arif Nasir |
250,900 |
5.30 |
|
2025-06-09 |
13D/A |
URGN / UroGen Pharma Ltd. |
Monograph Capital Partners I, L.P. |
838,615 |
1.90 |
|
2025-06-09 |
13D/A |
RFL / Rafael Holdings, Inc. |
Jonas Howard S |
14,688,994 |
28.40 |
|
2025-06-09 |
13D/A |
RFL / Rafael Holdings, Inc. |
i9 PLUS, LLC |
3,616,431 |
7.00 |
8.33 |
2025-06-09 |
13D/A |
AYTU / Aytu BioPharma, Inc. |
Nantahala Capital Management, LLC |
1,086,812 |
14.40 |
0.00 |
2025-06-09 |
13D/A |
NATR / Nature's Sunshine Products, Inc. |
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. |
2,918,774 |
15.90 |
2.25 |
2025-06-09 |
13D/A |
PLUR / Pluri Inc. |
Chen Franco-Yehuda |
40,064 |
0.51 |
|
2025-06-06 |
13D |
ACNT / Ascent Industries Co. |
Jumana Capital Investments LLC |
521,819 |
5.50 |
|
2025-06-06 |
13D/A |
ANIX / Anixa Biosciences, Inc. |
Kumar Amit |
6,173,097 |
16.30 |
9.19 |
2025-06-06 |
13D/A |
TYRA / Tyra Biosciences, Inc. |
Ra Capital Management, L.p. |
11,899,788 |
22.40 |
11.37 |